Information:
Error:
ID
13118
Description
Immunotherapy With APC8015 (Sipuleucel-T, Provenge) for Asymptomatic, Metastatic, Hormone-Refractory Prostate Cancer; ODM derived from: https://clinicaltrials.gov/show/NCT01133704
Link
https://clinicaltrials.gov/show/NCT01133704
Keywords
Versions (1)
- 1/17/16 1/17/16 -
Uploaded on
January 17, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Eligibility Hormone-Refractory Prostate Cancer NCT01133704
Eligibility Hormone-Refractory Prostate Cancer NCT01133704
- StudyEvent: Eligibility
Similar models
Eligibility Hormone-Refractory Prostate Cancer NCT01133704
- StudyEvent: Eligibility
Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
prostate adenocarcinoma
Item
histologically documented adenocarcinoma of the prostate
boolean
C0019638 (UMLS CUI [1,1])
C0007112 (UMLS CUI [1,2])
C0007112 (UMLS CUI [1,2])
metastasis
Item
metastatic disease as evidenced by soft tissue and/or bony metastases
boolean
C0027627 (UMLS CUI [1])
psa
Item
prostate-specific antigen value of at least 5 ng/ml
boolean
C0138741 (UMLS CUI [1])
tumor progression while on hormone therapy
Item
tumor progression while on hormonal therapy
boolean
C0178874 (UMLS CUI [1,1])
C0279025 (UMLS CUI [1,2])
C0279025 (UMLS CUI [1,2])
testosterone
Item
castration levels of testosterone (defined as less than 50 ng/dl)
boolean
C0523912 (UMLS CUI [1])
life expectancy
Item
life expectancy of at least 16 weeks
boolean
C0023671 (UMLS CUI [1])
organ function
Item
adequate hematologic, renal, and liver function
boolean
C0232741 (UMLS CUI [1,1])
C0005953 (UMLS CUI [1,2])
C0232804 (UMLS CUI [1,3])
C0005953 (UMLS CUI [1,2])
C0232804 (UMLS CUI [1,3])
visceral metastases
Item
visceral organ metastases
boolean
C0027627 (UMLS CUI [1,1])
C0442045 (UMLS CUI [1,2])
C0442045 (UMLS CUI [1,2])
radiation therapy
Item
metastatic disease expected to be in need of radiation therapy within 4 months.
boolean
C1522449 (UMLS CUI [1])
study subject participation status, concurrent therapy
Item
concurrent therapy with experimental agents
boolean
C2348568 (UMLS CUI [1])
C0009429 (UMLS CUI [2])
C0009429 (UMLS CUI [2])